ArticleACS medicinal chemistry letters2024

Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment.

Roland W Bürli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.